Rozental & Herman SRL
Rozental & Herman reported total assets of €1.05m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Dec 2025).
By total assets for 2025, Rozental & Herman ranks in the top half of the 3,805 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Rozental & Herman shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +3533 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Rozental & Herman's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 30 Dec 2025
- Year ended 30 Jun 2024filed on 28 Jan 2025
- Year ended 30 Jun 2023filed on 24 Jan 2024
- Year ended 30 Jun 2022filed on 27 Jan 2023
Rozental & Herman's financial analysis
- Solvency0.7%sector median: 40.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Rozental & Herman
Rozental & Herman's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0766.880.119
- VAT number
- BE0766880119
- Peppol
- Registered · 0208:0766880119 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Apr 2021
- Registered office
- 6042 Charleroi
- Latest accounts
- 2025 · filed on 30 Dec 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Rozental & Herman (SRL) has been based in Charleroi since 2021, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 19,426 € and equity of 7,826 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Rozental & Herman
Companies in the same business, of comparable size and area, outside its group.
- ANAP Retail sale of pharmaceutical products Aalst · balance sheet €1.37m
- Mylle Pharma Retail sale of pharmaceutical products Anzegem · balance sheet 947,525 €
- Pharmanaus Retail sale of pharmaceutical products Herve · balance sheet €1.18m
- Thomas Broos Retail sale of pharmaceutical products Herent · balance sheet €1.19m
- Pharmacie d'Helecine Retail sale of pharmaceutical products Hélécine · balance sheet €1.22m
- Apotheek het Perron Retail sale of pharmaceutical products Poperinge · balance sheet 862,885 €
- Cosmephar Retail sale of pharmaceutical products Antwerp · balance sheet 561,007 €
- VRB Farma Retail sale of pharmaceutical products Mechelen · balance sheet 551,620 €
Frequently asked questions about Rozental & Herman
What is the revenue of Rozental & Herman?
Rozental & Herman files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Rozental & Herman?
In Belgium, the VAT number is the company number prefixed with BE: BE0766880119 for Rozental & Herman, if the company is VAT-registered. Its company number (CBE) is 0766.880.119.
Where is the registered office of Rozental & Herman?
According to the CBE register, the registered office of Rozental & Herman is in 6042 Charleroi.
What is the equity of Rozental & Herman?
At the close of the 2025 financial year, the equity of Rozental & Herman amounts to 7,826 €, a solvency of 0.7% of total assets.
Who manages Rozental & Herman?
The register lists 2 active mandates at Rozental & Herman. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Rozental & Herman within its sector?
By total assets for 2025, Rozental & Herman ranks in the top half of the 3,805 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year.
The full file of Rozental & Herman
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →